HOME Intervention for Postpartum Health
(HOME Trial)
Trial Summary
What is the purpose of this trial?
The goal of this educational clinical trial is to identify Black women most at risk for poor outcomes following delivery, the problems they experience, and to create a system to improve quality of postpartum care for high-risk women. The main question\[s\] it aims to answer are: * How can the investigators help postpartum Black people who have poor outcomes by decreasing the number of ED visits/readmissions for postpartum people within the first 30 days postpartum? * How can the investigators increase the ability of participants to "obtain needed services" and ability for patients to see their provider when they need to, in the 30-day post discharge period as one of the main pathways of unnecessary ED visits? Participants will be put into the study group or control group. The study group will receive a pamphlet postpartum with helpful information as well as a patient navigator who the participants will be able to reach out to their first 30 days postpartum.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the HOME Discharge Planning Intervention treatment for postpartum health?
Is the HOME Intervention for Postpartum Health safe for humans?
The available research on discharge planning interventions, including those similar to the HOME Intervention, focuses on improving patient care and reducing adverse events after hospital discharge. While specific safety data for the HOME Intervention in postpartum health is not provided, these types of interventions generally aim to enhance safety and care during the transition from hospital to home.16789
How is the HOME Intervention for Postpartum Health different from other postpartum treatments?
The HOME Intervention for Postpartum Health is unique because it focuses on flexible, client-centered planning for postpartum care at home, which allows for personalized care that adapts to the diverse and changing needs of new mothers. This approach contrasts with traditional postpartum care that often involves standard procedures and less personalized attention.1011121314
Eligibility Criteria
This trial is for postpartum Black women aged 18 or older who have recently delivered at the Hospital of University of Pennsylvania. Participants must speak English, be able to read, and meet certain risk criteria as determined by a prediction model.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a patient education pamphlet and partner sheet, and are supported by a patient navigator for 30 days postpartum
Follow-up
Participants are monitored for safety and effectiveness after treatment, focusing on ED visits and readmissions
Treatment Details
Interventions
- HOME (Behavioral Intervention)
HOME is already approved in Canada for the following indications:
- Improving daily life activities for frail older adults
- Reducing hospital and emergency readmissions
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pennsylvania
Lead Sponsor
National Institutes of Health (NIH)
Collaborator
Columbia University
Collaborator
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborator